tiprankstipranks
Biogen (BIIB)
NASDAQ:BIIB
US Market

Biogen (BIIB) Technical Analysis

Compare
4,764 Followers

Technical Sentiment

Overall Consensus
Sell
4Bullish
4Neutral
14Bearish
Technical Analysis Consensus
Buy
4Bullish
4Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Biogen’s (BIIB) Moving Averages Convergence Divergence (MACD) indicator is -0.55, suggesting Biogen is a Buy.
Biogen’s (BIIB) 20-Day exponential moving average is 141.96, while Biogen’s (BIIB) share price is $139.16, making it a Sell.
Biogen’s (BIIB) 50-Day exponential moving average is 144.51, while Biogen’s (BIIB) share price is $139.16, making it a Sell.

Biogen (BIIB) Pivot Points

Mar 26, 2025, 10:21 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
136.58
138.61
140.10
142.13
143.62
145.65
147.14
Fibonacci
138.61
139.95
140.78
142.13
143.47
144.30
145.65
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Biogen (BIIB) Moving Averages

Mar 26, 2025, 10:21 PM
Period
Simple
Exponential
MA5
140.89Sell
140.78Sell
MA10
141.07Sell
141.48Sell
MA20
142.59Sell
141.96Sell
MA50
142.22Sell
144.51Sell
MA100
150.80Sell
153.66Sell
MA200
179.22Sell
175.60Sell
Biogen’s (BIIB) 10-Day exponential moving average is 141.48, while Biogen’s (BIIB) share price is $139.16, making it a Sell.
Biogen’s (BIIB) 100-Day exponential moving average is 153.66, while Biogen’s (BIIB) share price is $139.16, making it a Sell.
Biogen’s (BIIB) stock price is $139.16 and Biogen’s (BIIB) 50-day simple moving average is 142.22, creating a Sell signal.
Biogen’s (BIIB) stock price is $139.16 and Biogen’s (BIIB) 100-day simple moving average is 150.80, creating a Sell signal.
Biogen’s (BIIB) stock price is $139.16 and Biogen’s (BIIB) 200-day simple moving average is 179.22, creating a Sell signal.

Biogen (BIIB) Technical Indicators

Mar 26, 2025, 10:21 PM
Name
Value
Implied Action
RSI (14)
43.22
Neutral
STOCH (9,6)
21.60
Neutral
STOCHRSI (14)
10.42
Buy
MACD (12,26)
-0.55
Buy
ADX (14)
15.20
Buy
Williams %R
-97.13
Buy
CCI (14)
-77.78
Neutral
ATR (14)
4.11
-
Ultimate Oscillator
35.88
Neutral
ROC
-3.21
Sell
Biogen’s (BIIB) Relative Strength Index (RSI) is 43.22, creating a Neutral signal.
Biogen’s (BIIB) Trend Strength Indicator (ADX) is 15.20, creating a Buy signal.
Biogen’s (BIIB) Commodity Channel Index (CCI) is -77.78, creating a Neutral signal.
Biogen’s (BIIB) Price Rate of Change (ROC) is -3.21, creating a Sell signal.

FAQ

Is BIIB a Buy, Hold, or Sell?
Based on BIIB’s technical indicators, BIIB is a Sell.
    What is BIIB’s RSI (14)?
    BIIB’s RSI (14) is 43.22, which suggests BIIB is a Neutral.
      What is BIIB’s MACD?
      BIIB’s MACD is -0.55, which suggests BIIB is a Buy.
        What is BIIB’s 5-day moving average?
        BIIB’s 5-day moving average is 140.89, which suggests BIIB is a Sell.
          What is BIIB’s 20-day moving average?
          BIIB 20-day moving average is 142.59, which suggests BIIB is a Sell.
            What is BIIB’s 50-day moving average?
            BIIB’s 50-day moving average is 142.22, which suggests BIIB is a Sell.
              What is BIIB’s 200-day moving average?
              BIIB’s 200-day moving average is 179.22, which suggests BIIB is a Sell.
                What is BIIB’s Williams % R (14)?
                BIIB’s Williams % R (14) is -97.13, which suggests BIIB is a Buy.
                  What is BIIB’s CCI (14)?
                  BIIB’s CCI (14) is -77.78, which suggests BIIB is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis